Table 1.
Baseline clinical and demographic characteristics of the patients.
| Variable | Frequency | Percent (%) |
| Age (yr) | ||
| Mean ± SD | 34.56 ± 10.19 | |
| Range | 18–60 | |
| Gender | ||
| Male | 33 | 63.5 |
| Female | 19 | 36.5 |
| HIV | ||
| Yes | 18 | 34.6 |
| No | 34 | 65.4 |
| Smoking | ||
| Yes | 15 | 28.8 |
| No | 37 | 71.2 |
| HTN | ||
| Yes | 3 | 5.8 |
| No | 49 | 94.2 |
| DM | ||
| Yes | 2 | 3.8 |
| No | 50 | 96.2 |
| Weight (kg) | ||
| Mean ± SD | 70.62 ± 17.90 | |
| BMI (kg/m2) | ||
| Mean ± SD | 25.23 ± 5.98 | |
| CD4 (cells/μL) | ||
| Mean ± SD | 282.44 ± 131.94 | |
| Interval between the 2 PET scans (mo) | ||
| Mean ± SD | 24.06 ± 21.53 | |
| Interval between completion of chemotherapy and post-chemo-PET scan (wk) | ||
| Mean ± SD | 64.67 ± 88.41 | |